We have studied the effects of nitrous oxide on cerebral blood flow (CBF), cerebral blood flow velocity (CBFV) and intracranial pressure (ICP) during isoflurane-induced hypotension in 10 pigs. CBF was measured using laser Doppler flowmetry, CBFV in the right middle cerebral artery was calculated using Doppler ultrasound and ICP was measured using an extradural ICP monitor. Each animal was studied under four conditions, examined sequentially: (i) mean intra-arterial pressure (MAP) 85 mm Hg, maintained with isoflurane, (ii) MAP 50-55 mm Hg, induced by isoflurane only, (iii) MAP 85 mm Hg, maintained with isoflurane and 50% nitrous oxide, and (iv) MAP 50-55 mm Hg, induced by isoflurane and 50% nitrous oxide. No significant differences were noted between conditions with respect to ICP. There was a significant difference in CBF during condition (ii) compared with (i) (mean 75(SD 21) vs 100(0) %) and during condition (iv) compared with (iii) (90(26) vs 109(13)%). Animals under condition (iv) exhibited a 20% reduction in CBFV compared with those under condition (iii) (57 vs 69 cm s~1). For animals under normotensive conditions, addition of nitrous oxide to isoflurane resulted in a 16% increase in CBFV (69 vs 60 cm s~1). Comparing isofluraneinduced hypotension ((ii) vs (iv)), there was no statistical difference in either CBF or CBFV on addition of 50% nitrous oxide. The correlation between changes in CBF and CBFV was not significant. We conclude that the use of nitrous oxide during isoflurane-induced hypotension has no significant effect on CBF, CBFV or ICP compared with the use of isoflurane alone. (Br. J. Anaesth. 1994; 73: 667-672) Key words Anaesthetic techniques, hypertensive. Anaesthetics gases, nitrous oxide. Anaesthetics volatile, isoflurane. Brain, blood flow. Brain, intracranial pressure. Pig.
Isoflurane decreases the cerebral metabolic rate for oxygen (CMRo 2 ) while maintaining adequate cerebral blood flow (CBF) [1] . In addition, it produces systemic vasodilatation with little myocardial depression during hypotensive anaesthesia [2, 3] . These attributes support the use of isoflurane in hypotensive anaesthesia. Nitrous oxide has been a common component of neuroanaesthetic practice for decades. Many clinicians use a combination of nitrous oxide and inhalation agent to reduce the required concentration of inhalation agent known to increase CBF and intracranial pressure (ICP) [4, 5] . However, some studies have shown that the effects of nitrous oxide on cerebral haemodynamic state and metabolism are substantial and particularly evident when administered in combination with an inhalation anaesthetic [5] [6] [7] [8] [9] . Clinically, nitrous oxide is used frequently during isoflurane-induced hypotension. The purpose of the present study was to observe the cerebral effects of nitrous oxide during isoflurane-induced hypotension. We measured CBF in the parietal cortex by laser Doppler flowmetry, peak flow velocity of the right middle cerebral artery by Doppler sonography and ICP by extradural intracranial pressure monitoring.
Materials and methods
This study was approved by the National Science Council of Taiwan. We studied 10 unmedicated fasting pigs with a mean weight of 9.5 (SD 2.4) kg. Anaesthesia was induced with ketamine 10 mg kg" 1 i.m. and atropine 0.05 mg kg" 1 i.m. and maintained with isoflurane and vecuronium. The trachea was intubated and ventilation controlled to maintain normocapnia (Pa COi x 5.3 kPa) by adjusting ventilatory frequency or the deadspace of the anaesthetic circuit. A cannula was inserted into the femoral artery for continuous pressure measurement and blood sampling, and another into a peripheral vein for fluid and drug administration. Rectal temperature was monitored and maintained near 36 °C with a servocontrol heating pad. Fluid was infused continuously with saline (3-4 ml kg" 1 h" 1 ). The animal was then turned to the sphinx position and the head was fixed in a stereotaxic frame. For measurement of cerebral blood flow, a burr hole (2.5 mm in diameter) was placed over the left parietal bone (1.2 cm left lateral to the sagittal suture and 1.2 cm rostral to the coronal suture) using a dental drill. Another cranial burr hole (1.5 cm in diameter) was placed in the right temporal area (1 cm left to the inner margin of the right ear) for measurement of cerebral flow velocity. The dura remained intact at both windows.
After completion of the surgical preparation, the experiment was undertaken with two pairs of measurements. In both pairs, measurements were obtained during normotension and then during isoflurane-induced hypotension. In the first pair, isoflurane administration was continued at the level needed to maintain hypotension. In the second pair, isoflurane administration was continued as in the first pair but in addition 50% nitrous oxide was added to the inspired gas. The reverse order was not studied. Therefore, four experimental conditions were studied sequentially: (i) mean intra-arterial pressure (MAP) of 85 mm Hg (normotensive), maintained with isoflurane, (ii) MAP 50-55 mm Hg (hypotensive), induced by isoflurane only, (in) MAP 85 mm Hg, maintained with isoflurane and 50 % nitrous oxide, and (iv) MAP 50-55 mm Hg, induced by isoflurane and 50% nitrous oxide. MAP was allowed to return to condition (i) by adjustment of isoflurane concentration before initiation of condition (iii). A period of 30-45 min was allowed to achieve equilibration at each desired condition. An additional 15 min, at least, was allowed to ensure stable arterial pressure and unchanged end-tidal anaesthetic and carbon dioxide concentrations. All variables, including MAP and heart rate (Datex, Cardiocap, CMO-104), arterial carbon dioxide partial pressure (blood-gas system, Ciba-Corning 288), end-tidal anaesthetics (Datex, CapnoMac, AGM-103), CBF by laser Doppler flowmeter, peak flow velocity of the right middle cerebral artery by ultrasound Doppler and ICP by extradural intracranial pressure monitor, were measured during the subsequent 5 min.
LASER DOPPLER FLOWMETRY FOR CEREBRAL BLOOD FLOW
Cerebral blood flow was measured by a PeriFlux PF2 Doppler flowmeter (Perimed, Sweden). A needle-type probe (2.5 mm in diameter) from a laser Doppler blood flowmeter was positioned on the dura without identing. Large dural or pial blood vessels were avoided. The probe was secured by a stereotaxic system fixed to the skull via two screws. The values displayed by the instrument, designated here as CBFu,,, were given as a percentage of the value obtained during normotensive condition (i), which was taken as baseline and set at 100 %. The principle of operation of laser Doppler flowmetry is detailed elsewhere [10, 11] .
CEREBRAL BLOOD FLOW VELOCITY MEASUREMENT
Using the cranial window opened in the right temporal bone, cerebral blood flow velocity (CBFV) was measured with a 2-MHz ultrasonic probe placed on the intact dura and fixed in a frame. Placement of the probe was established by flow direction analysis, depth control and audioanalysis. Although the precise angle between the probe and vessel was not determined, the animal's head and the probe was secured, keeping the angle fixed during the experiment. The stability of the angle was essential for good ultrasonic resolution. CBFV was taken as the peak flow velocity (cm s~') of the middle cerebral artery and was monitored continuously using a Doppler ultrasound instrument (Medasonics 1024s).
INTRACRANIAL PRESSURE MONITORING
ICP was measured using a Ladd intracranial pressure monitor (Ladd Research Industries Inc.) [12] . This device is based on an air-filled balloon system and is designed specifically for measurement of ICP. Zero adjustment was made automatically with the extradural probe in situ, thus avoiding zero drift. The probe was placed directly in the extradural space, through the window opening used for CBFV.
STATISTICAL ANALYSIS
Variables between conditions were compared using ANOVA for repeated measures. Post hoc comparisons between study conditions were made using Fisher's PLSD test. P < 0.05 was considered significant. Statistical calculations were performed on a Macintosh computer, using a commercial statistics package (Statview, Abacus Concepts Inc.). The relationship between the changes in CBF^p and CBFV was examined using linear regression analysis. All results are expressed as mean (SD).
Results
Data for MAP, heart rate, end-tidal isoflurane concentration and arterial carbon dioxide partial pressure are shown in table 1. Stable target MAP values defining both normotensive (85 mm Hg) and hypotensive (53 mm Hg) conditions were achieved. Mean heart rate was modestly lower (108 vs 123 beat min" 1 , P > 0.05) during hypotension. When used alone, isoflurane concentrations necessary to achieve normotension and hypotension were 0.8 and 1.9%, respectively. Similarly, using isoflurane with 50% nitrous oxide, these values were 0.5 and 1.7 %, respectively, Pa<zo was maintained within the desired level in each condition.
Values for cerebral perfusion pressure (CPP), ICP, CBF^,, and CBFV are shown in table 2. CPP was calculated by subtracting ICP from MAP. Both normotensive conditions exhibited a CPP value of approximately 80 mm Hg, while this value was approximately 50 mm Hg during both hypotensive conditions. There were no significant differences between conditions with respect to ICP. A significant difference in CBF^p was observed between hypotensive and normotensive conditions whether the anaesthetic was isoflurane alone (75 vs 100%) or isoflurane combined with 50 % nitrous oxide (90 vs 109%). Using isoflurane with nitrous oxide, during hypotension animals exhibited a 20% reduction in CBFV compared with those during normotension (57 vs 69 cm s" 1 ). During normotension the addition of nitrous oxide to isoflurane resulted in a 16% increase in CBFV (69 vs 60 cm s~')-Comparing isoflurane-induced hypotensive conditions ((ii) vs (iv)), there was no statistical difference in CBF (P = 0.07) or CBFV after addition of 50% nitrous oxide. Designating as 100% CBFV under normotensive conditions with isoflurane alone, figure 1 shows that CBFV and CBFu,, followed a similar trend during the course of the four sequential conditions. However, the magnitude of the change was noticeably different. The correlation between the changes in CBF^p and CBFV was not significant (r = 0.24, P > 0.05).
Discussion
To avoid unstable haemodynamic conditions when nitrous oxide was added [13, 14] , the conditions with isoflurane and nitrous oxide always followed conditions with isoflurane alone. We considered the possibility that the time sequence might have had some influence on the results. It may have been preferable to randomize the order of each manoeuvre and control conditions achieved between each experimental condition. However, two factors lead us to believe that this was not a major problem. First, with the addition of nitrous oxide, values for CBFu,, and CBFV in nine of 10 animals were greater than those with isoflurane alone during normotension, suggesting that the progressive decrease in CBFu,, and CBFV that might be expected in a deteriorating preparation was not occurring. Second, the minimal alveolar concentration (MAC) of isoflurane or isoflurane with 50 % nitrous oxide required to reach the same MAP was higher with the combination of isoflurane and nitrous oxide than that with isoflurane alone. It is known that 10 % nitrous oxide is equal in anaesthetic potency to 0.1% isoflurane [15] . Thus 50% nitrous oxide is equivalent to 0.5% isoflurane anaesthesia. The MAC of isoflurane with 50% nitrous oxide was higher than that of isoflurane alone. This is in keeping with previous observations on equianaesthetic levels; the use of nitrous oxide with isoflurane is associated with a higher arterial pressure than that observed when isoflurane alone is used in pigs or humans [16] [17] [18] .
Six of 10 pigs had reductions in heart rate during hypotension compared with normotension with either isoflurane alone or isoflurane and nitrous oxide in our study, although no significant differences were noted. In the pig study of Manohar and Parks, mean heart rate changed from 140 (SD 6) to 125 (8) beat min" 1 (P > 0.05) and mean aortic pressure from 87 (4) to 69 (4) mm Hg (P < 0.05) during isoflurane anaesthesia from 1 to 1.5 MAC; if combined with 50% nitrous oxide to reach the same MAC, heart rate changed from 157 (7) to 156 (8) beat min" 1 (P > 0.05) and mean aortic pressure from 100 (4) to 86 (6)mmHg (P < 0.05) [16] . In the human study, changes in heart rate were not significant during isoflurane-induced hypotension for intracranial vascular surgery compared with normotensive condition [19, 20] . Unlike sodium nitroprusside-induced hypotension, isoflurane-induced hypotension attenuates the stress response to hypotension allowing good control of MAP and heart rate [21] . Also, isoflurane anaesthesia depresses baroreflex control of heart rate in humans at 1.0 and 1.5 MAC [22] .
In the present study, we used laser Doppler flowmetry to measure CBF and Doppler ultrasound to measure CBFV in the middle cerebral artery. Both techniques are sensitive to changes in probe position and to movement of the transmission fibre between the probe and instrument. To achieve optimal signals, both probes were well secured in a constant position and the animal was firmly immobilized.
Laser Doppler flowmetry measurements compare well with other methods for measuring CBF, including radiolabelled microspheres, hydrogen clearance and quantitative autoradiography [11, [23] [24] [25] [26] [27] [28] . Some investigators have suggested that changes in CBFV, as demonstrated by the ultrasound Doppler technique, are closely related to simultaneous changes in CBF [29] [30] [31] [32] [33] [34] . However, in a rabbit study by Hasegawa and colleagues [35] , CBFV and CBFu,, differed in response to changes associated with dilatation or constriction of cerebral vessels induced with carbon dioxide, although they showed similar changes in response to hypoxia. In our study, changes in CBFu, F correlated poorly with those of CBFV. The magnitude of the increase in CBFV was greater than the increase in CBFu,,, during normotension maintained with isoflurane and 50 % nitrous oxide (16 % vs 9 %). However, CBFu, F decreased to a greater extent than CBFV during both hypotensive conditions. Using isoflurane alone, CBFV decreased 10% compared with a decrease of 25% in CBFu,,,; when combined with nitrous oxide, the decreases were 4% and 10%, respectively.
The inconsistent changes in CBFu^, and CBFV observed may reflect inherent variabilities between the laser Doppler flowmetry and Doppler ultrasound techniques. Laser Doppler flowmetry measures blood flow by direct detection of blood velocity and volume flowing through microvessels [25, 36] . However, the ultrasound Doppler technique provides information only on blood flow velocity, not volume. In addition, Doppler signals are sensitive to the diameter of the insonated vessel segment, and there is evidence in the literature that the cross-sectional area of cerebral arteries is not constant [33, 37] . If changes in blood vessel diameter occur during measurement, blood flow velocity does not serve as a good indicator of changes in CBF [38, 39] . In general, the two techniques also measure substantially different sized blood vessels. Laser Doppler flowmetry, which examines a small sample volume and imparts a high spatial resolution, was appropriate for measurement of the highly localized cerebral microcirculation [40] . Use of the ultrasound Doppler method for measurement of blood flow velocity in the middle cerebral artery was dictated by the large diameter of this vessel. The need to use vessels of disparate size, and thus the use of different techniques, contributes in an unknown fashion to changes in CBFu,,, and CBFV. Finally, there may exist a difference in response to anaesthetics between small and large calibre vessels of the brain.
Other studies have shown that the addition of nitrous oxide to halothane or isoflurane results in greater CBF than each agent alone [4, 5] ; these increases were observed while maintaining a constant MAP by i.v. infusion of vasopressor. The influence of MAP on CBF is important in such studies. In a study by Manohar and Parks using pigs [16, 41] , the addition of 50% nitrous oxide to maintain equipotent anaesthesia compared with isoflurane alone markedly exaggerated the increment in CBF but MAP was significantly greater in those animals receiving 50% nitrous oxide. Also, in a study by Lam and co-workers in humans [17] , addition of 0.6 MAC of nitrous oxide to 0.5 MAC of isoflurane resulted in a significantly greater CBFV than equipotent isoflurane alone (56 vs 44 cm s" 1 ). Again, however, MAP was not kept constant between groups. Newberg, Milde and Michenfelder [1, 2] , using a sagittal sinus outflow technique in dogs, found that CBF was reduced by 60% during isoflurane-induced hypotension (MAP = 50 mm Hg) compared with a control group (MAP = 125 mm Hg). Our results indicate that during hypotension with either isoflurane or isoflurane and 50% nitrous oxide, CBFu^ was decreased significantly compared with the corresponding normotensive condition.
The equation, arterial pressure = blood flow x vascular resistance, may explain our results. Both isoflurane and nitrous oxide are cerebral vasodilators [4] [5] [6] . As cerebral blood flow decreased when MAP was reduced with either isoflurane alone or isoflurane with 50% nitrous oxide, it appeared that cerebral vasodilatation (decrease in resistance) was inadequate to maintain cerebral blood flow. Comparing isoflurane-induced hypotensive conditions in our study, there was no statistical difference (P = 0.07) in CBFu,,, observed on addition of 50% nitrous oxide. However, CBFu^, when using nitrous oxide, tended to be larger (see fig. 1 ). These data support the concept that the combination of nitrous oxide and isoflurane produces a greater degree of vasodilatation than that of isoflurane alone during isoflurane-induced hypotension.
Intracranial pressure was measured using an extradural ICP monitor, which was shown to be a simple, non-invasive and reliable approach in the measurement of ICP in newborn infants [12, 42, 43] . Yet the gold standard is intraventricular measurement. Small changes in ICP may relate to the relative insensitivity of the extradural measurement compared with other techniques. However, in common with our results, Newberg, Milde and Michenfelder also demonstrated a decrease in cerebral blood flow without significant changes in ICP after isofluraneinduced hypotension [2] . Both studies failed to observe significant changes in ICP during the hypotensive period compared with the normotensive period. This may reflect the highly compliant intracranial space of normal animals studied in a head-up position.
It has been presumed that an increase in CBF predicts an increase in ICP. However, ICP is determined by cerebral blood volume (CBV), not CBF [44] . In some circumstances, such as hypercapnia, there is a positive correlation between CBV and CBF [45] ; however, other conditions, such as vasodilatation, cause an increase in CBV while CBF either remains constant or decreases [46, 47] . Although patients with reduced intracranial compliance experience an increase in ICP on administration of isoflurane or nitrous oxide [48] [49] [50] [51] [52] , the effects of nitrous oxide on ICP in normal animals or humans is inconsistent [53, 54] .
Measured by positron emission tomography, CBV was reported to be increased in dogs during administration of isoflurane or nitrous oxide when MAP was maintained constantly [7] . As measurement of laser Doppler flowmetry involves the use of power information derived from the signal which relates specifically to the blood volume of the interrogated area, we might be able to assess changes in CBV. However, CBFu,,, decreased during isoflurane-induced hypotension compared with normotension in our study. CBF is not kept constant by cerebral vasodilatation, suggesting that autoregulation might be attenuated or abolished. CPP is reduced, thus driving pressure is decreased. In this circumstance, there are many possible combinations of changes in arterial velocity and blood volume through microvessels. As the change in ICP was small, although it showed a trend towards decrease during hypotension, we suggest that the change in CBV was not a major factor in this setting.
In summary, the combined use of isoflurane and nitrous oxide during isoflurane-induced hypotensive anaesthesia had no significant effect on CBFUJ,, CBFV or ICP compared with isoflurane alone.
